Oluyemi Okupe - 19 Aug 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 16:30:37 UTC
Prior SEC filing
20 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe

Key filing fact

Oluyemi Okupe filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 20 Aug 2026.

Key facts

  • This page summarizes Oluyemi Okupe's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Aug 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 20 Jul 2026.
  • Current net transaction value: -$148,111.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001907056 Primary reporting owner

Okupe Oluyemi

Relationship
Chief Financial Officer
Address
2269 CHESTNUT STREET, #523, SAN FRANCISCO
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe
Signature date
20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+4,938
Change %
+1.9%
Price
$5.01*
Shares after
269,055
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1
HIMS transaction

Class A Common Stock

Sale

Transaction value
$148,111
Shares
-4,938
Change %
-1.8%
Price
$29.99
Shares after
264,117
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1, F2
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,853
Date
19 Aug 2026
Ownership
Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIMS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-4,938
Change %
-5.8%
Price
$0.000000*
Shares after
80,872
Date
19 Aug 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
4,938
Exercise price
$5.01
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Footnote F2

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F3

25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .